Skip to content

Optimal Timing for post ERCP laparoscopic cholecystectomy

Optimal timing (Early vs Delayed) of Laparoscopic Cholecystectomy after Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis: A Randomized Control Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037091
Enrollment
152
Registered
2021-10-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K80- Cholelithiasis Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Laparoscopic Cholecystectomy: Early vs Delayed Laparoscopic Cholecystectomy after Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis Intervention2: Early Laparoscopi

Sponsors

ROUNAK MEHROTRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of 18 years and older who will undergo first successful ERCP with stone extraction and complete CBD clearance for gall stone disease with choledocholithiasis at Dept. of Gastroenterology.

Exclusion criteria

Exclusion criteria: 1. Not giving consent/declined surgery. 2. Post ERCP patients having active cholangitis (as diagnosed at Dept. of Gastroenterology). 3. Patients having Acute cholecystitis prior to ERCP. 4. Patients undergoing LC along with other concomitant surgery in the same setting. 5. Patients with suspected gall bladder carcinoma. 6. Patients with moderate to severe pancreatitis prior to ERCP (as diagnosed at Dept. of Gastroenterology). 7. Patients with ERCP induced pancreatitis (as diagnosed at Dept. of Gastroenterology). 8. Patients with cardiovascular, pulmonary disease, coagulopathy, end-stage liver disease or kidney dysfunction, unable to tolerate anaesthesia. (above 2 conditions i.e. 6 & 7 will themselves have inflammatory response in area of surgery i.e. peri choledochal region)

Design outcomes

Primary

MeasureTime frame
â?¢ Composite outcome comprising of 1. Conversion from laparoscopic to open surgery. 2. Intraoperative complications comprising of bile duct injury, vascular injury, bowel injury 3. Post-operative complications including post-operative pancreato-biliary events :- post-operative course up to period of one month leading to the diagnosis of bile duct injury, vascular injury, bowel injury or requirement of any endoscopic or radiological drainage procedure will be considered. 4. Interval pancreato-biliary events â?? in the waiting period of surgery in delayed group if the patient develops - ï?§ Recurrent CBD stone, ï?§ Acute Cholangitis defined according to Tokyo Guidelines TG 18/13, ï?§ Acute pancreatitis based on clinical, biochemical, and imaging criteria and ï?§ Acute cholecystitis defined according to Tokyo Guidelines TG 18/13 Timepoint: Follow up one month post surgery

Secondary

MeasureTime frame
taken from skin incision to skin closure. Dissection time will be calculated from introduction of laparoscope in the peritoneal cavity till the dissection of GB from liver bed. â?¢ Hospital stay: The hospital stay will be calculated as the number of days in the hospital after surgery until the patient is deemed fit for discharge by the operating surgeon. â?¢ Need for readmission and interventions. Timepoint: Follow up one month post surgery

Countries

India

Contacts

Public ContactROUNAK MEHROTRA

AIIMS

mehrotra.rounak@gmail.com9919328924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026